Oncothyreon (ONTY) is a clinical-stage biopharmaceutical company. It develops and markets synthetic vaccines and small molecules that treat the lives and outcomes of cancer patients. This stock is trading up 5% to $2.27 in recent trading.
Today's Range: $2.15-$2.2852-Week Range: $1.71-$6.24 Volume: 336,000 Three-Month Average Volume: 699,088 >>5 Health Care Stocks Ready to Break Out From a technical perspective, ONTY is bouncing higher here right above its 50-day moving average of $2.08 with lighter-than-average volume. This move has started to push shares of ONTY into breakout territory, since the stock has taken out some near-term overhead resistance levels at $2.20 to $2.26. At last check, ONY has hit an intraday high of $2.28, and volume is well below its three-month average action of 699,088 shares. This move is quickly pushing ONTY within range of triggering a major breakout trade. That trade will hit if ONTY manages to take out some near-term overhead resistance levels at $2.34 to $2.42 with high volume. Traders should now look for long-biased trades in ONTY as long as it's trending above today's low of $2.14 or above $2.26, and then once it sustains a move or close above those breakout levels with volume that hits near or above 699,088 shares. If that breakout triggers soon, then ONTY will set up to re-fill some of its previous gap down zone from last December that started near $5.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts